Reference
Diaz-Diaz J, et al. Management of intravenous therapy for MS during COVID-19 pandemic. Multiple Sclerosis Journal 27 (Suppl. 2): 647 abstr. P779, 2021. Available from: URL: http://doi.org/10.1177/13524585211044667 [abstract]
Rights and permissions
About this article
Cite this article
Alemtuzumab/natalizumab/ocrelizumab. Reactions Weekly 1882, 34 (2021). https://doi.org/10.1007/s40278-021-05501-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-05501-x